Home > Hot topics
Kyoto University, Others Eye Clinical Trial of Drug Found with iPS Cell Use (News)

Kyoto, Aug. 1 (Jiji Press)—Kyoto University said Tuesday that it and three other major Japanese universities are slated to conduct the world's first clinical trial of a drug candidate discovered with the use of induced pluripotent stem (iPS) cells. A team at Kyoto University's Center for iPS Cell Research and Application, or CiRA, has examined whether and how each of 6,809 chemical compounds wo…

Kyoto University CiRA: Japan’s Leading Stem Cell Research Center

Induced pluripotent stem cells known as iPS cells have two crucial abilities: they can differentiate into the cells that build many of the body’s tissues and organs, and they can proliferate almost indefinitely. Established in April 2010, the Center for iPS Cell Research and Application (CiRA) at Kyoto University has been studying these cells and conducting cutting-edge research into their potential use in regenerative medicine.

Video highlights

New series

  • From our columnists
  • In the news